Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.

ABSTRACT: The rapidly spreading Coronavirus Disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2), represents an unprecedented serious challenge to the global public health community. The extremely rapid international spread of the disease with significant morbidity and mortality made finding possible therapeutic interventions a global priority. While approved specific antiviral drugs against SARS-CoV-2 are still lacking, a large number of existing drugs are being explored as a possible treatment for COVID-19 infected patients. Recent publications have re-examined the use of Chloroquine (CQ) and/or Hydroxychloroquine (HCQ) as a potential therapeutic option for these patients. In an attempt to explore the evidence that supports their use in COVID-19 pat

SUBMITTER: Hashem AM 

PROVIDER: S-EPMC7202851 | biostudies-literature | 2020 May - Jun

REPOSITORIES: biostudies-literature